Printer Friendly

PREVALENCE OF SUB CLINICAL HYPOTHYROIDISM IN SCHOOL CHILDREN (6-11 YEARS) OF DERA ISMAIL KHAN.

Byline: Muhammad Ramzan, Irshad Ali, Faiqah Ramzan, Fain Ramzan and Muhammad Hans Ramzan

ABSTRACT

Objective: To determine the prevalence of sub clinical hypothyroidism (hyperthyrotropinemia) in obese school children.

Methodology: This cross-sectional study was carried out in Department of Chemistry, Gomal University, Dera Ismail Khan, from June 2007 to August 2010 including eight primary schools of Dera Ismail Khan having mixed population with some of the wards belonging to high socioeconomic group. Thorough clinical examination excluded those suffering from chronic health problems. Height and weight of each child was taken according to standard anthropometric procedures. Body mass index and body mass status of each study subject was calculated according to Quetelet's Index and WHO criteria respectively. A total of 83 school children (6-11 years) were randomly selected among 1336 children. The sample included 23 (27.71%) normal weight children and 60 (72.28%) obese. Gender wise distribution of the sample was 48 (57.83%) boys and 35 (42.16%) girls. Free Thyroxin (FT) and Thyroid Stimulating Hormone (TSH) were measured using radioimmunoassay.

Results Hyperthyrotropinemia was the most commonly observed thyroid hormone dysfunction (8.43%) in the whole sample (n=83) and 8.33% in obese children compared with 3-8% in general population of the United States.

Conclusion: Sub clinical hypothyroidism is the most common finding in the childhood obesity. The prevalence of sub clinical hypothyroidism in the present study is 8.43% in the whole sample (n=83) compared with 3-8% in general population of the United States. It is suggested that all the obese children expressing minimum organ abnormalities be investigated to prevent the irreversible problems over the course of many years.

Keywords: Sub Clinical Hypothyroidism, Childhood Obesity, Cardiovascular risk factor

INTRODUCTION

Obese patients frequently show alterations of thyroid function that are now considered to be consequence rather than a cause of overweight/ obesity. Thyroid hormones and thyroid stimulating hormone concentration have been variously described as normal, elevated or even low in obese patients when compared with normal weight control individuals'2. Elevated serum TSH and thyroid hormone concentrations have also been reported in obese children1'3'4. A satisfactory explanation of these findings is not yet available; though several mechanisms leading to hyperthyro-tropinemia have been hypothesized, including increased leptin-mediated production of prothyrotropin-releasing hormone5, impaired feedback due to lowered number of T3 receptors in the hypothalamus and variations in peripheral deiodinase activity6.

Recently, it has been demonstrated that thyroid structure can be altered to different degrees in a group of overweight/obese children4. The structural changes observed by Ultrasound resembled those of typical Hashimoto's thyroiditis, which was excluded on the basis of the absence of anti thyroid antibodies. A completely normal cytological pattern was also observed by needle biopsy. The cause of these findings is still unknown.

The major concern with compensated hypothyroidism is that minimal end organ abnormalities may be present which are undetectable because of lack of sensitive peripheral indicators such as serum TSH for the pituitary. Such minimal abnormalities may lead to important irreversible problems over the course of many years. Lipid metabolism, myocardial function, linear growth and cognitive ability are some of the functions that may be adversely affected by Sub Clinical Hypothyroidism (SCH)7'8. Even mild impairment of cognitive functions may have negative consequences for the developing child, and even school achievements with in the normal range does not prove that the child would not have performed better if treated with L- thyroxin (L-T4). The issue of treatment is still a matter of debate9'10.

METHODOLOGY

The present study assesses the prevalence of thyroid hormones dysfunction in the primary school children of Dera Ismail Khan as assessed by Free Thyroxin (FT4) and Thyroid Stimulating Hormone (TSH) in randomly selected 83 children: normal weight = 23 (27.71%) and obese = 60 (72.28%). There were 48 boys (57.83%) and 35 girls (42.16%). Subjects were randomly selected among children from 08 primary schools of the study area. Thorough clinical examination excluded those suffering from chronic health ailments. Written permission was obtained from the parents and the principals of the institutions. Participation was voluntary. Weight and height of each child was taken according to standard anthropometric methods without foot wear and wearing minimum clothing. Body mass index of each study subject was determined according to Quetelet's Index. BMI number was plotted on Center for Disease Control and Prevention (CDC) gender specific growth charts 2-20 years to determine BMI-for-age-percentile.

Body mass status of each child was determined according to WHO criteria. Children having BMI-for-age- percentile 95th percentiles were considered obese. Normal or healthy weight children were having BMI-for-age between 5th and 85ti percentile and those between 85th to 95th percentile were overweight".

Determination of the Free Thyroxin (FT4) and Thyroid Stimulating Hormone (TSH) was the criteria for the assessment of thyroid function. Radioimmunoassay was used for the assessment of peripheral and central thyroid hormones at the Institute of Radiotherapy and Nuclear Medicine (IRNUM) at Peshawar, Pakistan. For FT4, RIA kit and TSH IRMA kit for TSH determination (IMMUNOTECH Czech Republic) were used. Normal serum concentration of FT4 was taken as 11.5 -23pmolIL and TSH = O.5-5jiIU/L12.

Descriptive statistics of lipid and thyroid hormone profile were calculated using the procedures given by Ott (1984)13 and Bhatti (2 006) 14 .

RESULTS

The present study investigated the prevalence of thyroid dysfunction with sub clinical hypothyroidism in the primary school children of Dera Ismail Khan as assessed by Free Thyroxin (FT4) and Thyroid Stimulating Hormone (TSH) in randomly selected 83 children: normal weight = 23 (27.71%) and obese = 60 (72.28%). There were 48 boys (57.83%) and 35 girls (42.16%). Distribution of the sample according to body mass status and gender is given in Table 1.

Table 2 summarizes the concentration of thyroid hormones in normal weight children. Mean, for the FT4 was centered at l5.3lpmol/L and 13.26Opmol/L in normal weight boys and girls respectively. Mean serum concentration of FT4 for the normal weight boys was observed higher than normal weight girls. Opposite to what was observed in normal weight boys for FT4, mean TSH serum concentration was measured higher in normal weight girls (3.48pJU/L) as compared to normal weight boys (2.7OjiIU/L). Thyroid dysfunction (SCH) was observed in 2 (8.6%) normal weight children (boys=2 and girls=0.O0).

Table 3 describes the serum levels for FT4 and TSH in obese children of the present study. Mean, for the FT4 in obese children was noted 13.2Opmol/L in boys and 13.74pmol/L in girls reflecting no significant gender difference compared to normal weight children. The mean serum level for the TSH in obese girls was noted higher (4.O6jiIU/L) as compared to obese boys (2.45jiIU/L). The gender difference for TSH was similar to what was observed in normal weight children. Thyroid dysfunction (SCH) was observed in 5 (8.33%) obese children (boys=3 and girls=2). Earlier, 3 children (normal weight = 2 and obese = 1) were detected to be having Hyperthyroidism and hypothyroidism and were excluded from the study.

Table 1: Sample Distribution of the School Children for the Biochemical and Hormonal Profile (n=83)

Body Mass Status Normal Weight Obese

Gender Boys Girls Boys Girls

N % N % N % N %

No. of Children 14 16.86 9 10.84 34 40.96 26 31.32

Total 23(27.71%) 60(72.28%)

Table 2: Hormonal Profiles (FT4 and TSH) of Normal Weight School Children (n = 23)

Serial Weight Boys (n = 14) Normal Weight Girls (n = 9)

Number Free T4(nmol/L) TSH(mIU/L) Free T4(nmol/L) TSH(mIU/L)

1 15.1 1.5 14.5 2.3

2 10.4 1.1 13.5 4.9

3 14.2 4.0 11.4 3.7

4 11.8 2.1 14.3 2.7

5 13.0 3.0 15.5 2.5

6 14.6 2.6 12.9 2.6

7 12.4 3.4 11.4 2.0

8 14.1 0.9 13.3 1.7

9 13.6 6.6 14.0 1.8

10 14.8 5.3 --- ---

11 14.4 2.1 --- ---

12 11.8 3.7 --- ---

13 11.6 1.9 --- ---

14 9.0 1.7 --- ---

Descriptive Statistics for Hormonal Profile of Normal Weight School Boys (n = 14)

Variable Mean S.D SE Mean Range p-Value

Free T4 15.31 9.46 2.44 9.00-48.90 0.011 (11)

TSH 2.707 1.666 0.430 0.70-6.60 0.014(1.5)

Descriptive Statistics for Hormonal Profi le of Normal Weight School Girls (n = 9)

Variable Mean S.D SE Mean Range p-Value

Free T4 13.260 1.391 0.440 11.40-15.50 0.019 (12)

TSH 3.480 2.681 0.848 1.70-10.60 0.044(1.5)

Table 3: Hormonal Profiles (FT4 and TSH) of Obese School Children (n = 60)

Serial Weight Boys (n = 34) Normal Weight Girls (n = 26)

Number Free T4(nmol/L) TSH(mIU/L) Free T4(nmol/L) TSH(mIU/L)

1 16.7 1.6 12.5 5.2

2 13.1 2.1 12.6 1.8

3 11.9 2.2 14.6 3.1

4 11.5 0.7 13.7 2.7

5 15.7 6.9 14.7 3.4

6 14.6 1.9 13.1 2.4

7 10.7 2.4 12.2 2.2

8 12.1 7.3 15.4 3.2

9 13.3 3.0 13.5 2.6

10 14.1 2.6 20.0 1.7

11 12.9 1.0 13.3 2.5

12 11.7 1.6 13.9 1.0

13 13.1 1.9 13.9 1.1

14 12.3 1.7 14.3 1.6

15 11.0 0.6 15.4 2.4

16 11.6 1.8 14.8 6.1

17 16.6 1.4 15.8 0.06

18 11.2 1.7 11.1 3.1

19 13.4 1.6 20.8 0.08

20 13.7 1.6 12.9 2.6

21 12.7 2.0 18.6 0.07

22 12.4 5.0 11.7 3.4

23 15.5 0.7 12.8 1.1

24 14.8 1.9 16.6 1.9

25 23.6 0.5 9.1 2.3

26 12.4 1.5 11.9 2.1

27 10.8 1.2 ---- ----

28 9.8 2.6 ---- ----

29 10.7 6.3 ---- ----

30 12.8 1.6 ---- ----

31 14.5 3.7 ---- ----

32 11.5 3.5 ---- ----

33 12.4 2.6 ---- ----

34 13.9 4.9 ---- ----

Descriptive Statistics for Hormonal Profiles of Obese School Boys (n = 34)

Variable Mean S.D SE Mean Range p-Value

Free T4 13.206 2.50 0.43 9.80-23.60 0.0083

TSH 2.459 1.73 0.30 0.50-7.30 0.0028

Descriptive Statistics for Hormonal Profiles of Obese School Girls (n = 26)

Variable Mean S.D SE Mean Range p-Value

Free T4 13.74 3.49 0.67 1.90-20.80 0.015

TSH 4.06 9.28 1.79 0.06-50.00 0.16

Table 4: Descriptive Statistics of Obese Children (n = 61)

Gender Boys (n = 34) Girls (n = 27)

Variable Mean +- SD Range Mean +- SD Range

WC (cm) 75.29 +- 8.25 60-93 75.52 +- 7.15 63-88

TG (mg/dl) 204.15 +- 55.48 109-375 238.10 +- 95.2 125-475

TC (mg/dl) 161.03 +- 21.19 119-230 172.37 +- 25.04 129-234

HDL-C (mg/dl) 33.79 +- 5.151 25-47 42.63 +- 7.33 29-60

LDL-C (mg/dl) 88.44 +- 17.69 62-146 102.70 +- 16.29 67-140

DISCUSSION

Obesity commonly coexists with hypothyroidism as a consequence or cause of it. Obesity affects hypothalamic-pituitary-thyroid axis directly or indirectly leading to alteration in thyroid function tests. The commonest observed change is alteration in thyroid stimulating hormone (TSH), Triiodothyronine (T3) and also of thyroxin (T4) hormones.

The present study was undertaken to assess the frequency of thyroid dysfunction (SCH) in school children of the study area. It included 83 children: normal weight = 23 and obese = 60 (Table 1). Both, normal as well as obese children were having thyroid dysfunction (normal weight = 2 and obese = 5). The prevalence of SCH was observed to be 8.69% and 8.33% in normal weight and obese children respectively (Table 2,3).

Sub Clinical Hypothyroidism, a mild thyroid failure, is diagnosed when peripheral thyroid levels (T4, T3) are within normal reference laboratory range, 11.5-23.5pmol/L12, but TSH is mildly elevated15. Ours findings can be compared with the findings reported by Hollowell et al, 200216, Karmisholt et al, 2008', that SCH generally occurs 3-8% in general population of the United States. Herrick, 200818 had reported the prevalence of SCH (4-8%) in the general population of the United States. Our rates for SCH are in agreement with the similar ones by Villar et al, 2007' in Brazil where prevalence of SCH was 4-8% in general population. Much higher rates (30%) for SCH have been reported by Han Kumar et al, 200820 in India. 50 overweight and obese children aged 2-18 years (overweight 20, obese 30) were evaluated for relationship between body mass index and TSH in euthyroid and SCH obese children and compared the serum TSH levels among obese and overweight children aged 6.4-18 years. SCH was found to be 30% in 9/30 obese children.

The major concern in children with compensated hypothyroidism is, that minimum end organ abnormalities may be present, which are undetectable because of lack of sensitive peripheral indicators such as TSH from the pituitary. Such minimal abnormalities may lead to important irreversible problems over the course of many years. Lipid metabolism, myocardial infarction, linear growth and cognitive ability are some of the functions that may be adversely affected by SCH.

Longitudinal studies suggest that 20-50% of individuals with SCH develop overt hypothyroidism with in 4-8 years7. The views expressed by the Surks and Ocampo, 1996, have been shared by the Vander pump et al, 199522 that the likelihood of progression of SCH to clinical hypothyroidism is 2.6-4.3% each year, if thyroperoxidase (TPO) antibodies are absent or present respectively.

Obese children with SCH (5/60) in the present study had more risk factors for cardiovascular disease (CVD) than those obese (as well as normal weight) without SCH. 4/5 (80%) among obese children with SCH had (greater than)3 CVD risk factors and altered lipid levels (Table 4). Altered lipid metabolism and development into overt hypothyroidism had also been reported by Surks and Ocampo, 1996. Ours study is in agreement with the Hack et al, 20008, that SCH adversely affects the lipid metabolism; myocardial infarction, linear growth and cognitive ability. Azad Reza et al, 200823, had expressed the similar views that SCH is associated with higher cholesterol, LDL-C compared with euthyroid controls.

Razvi et al, 200824, reported the increased incidence of ischemic heart disease (IHD), both in prevalence and incidence and cardiovascular mortality only in young subjects (less than 65 years) with SCH. However, Fatourechi, 200925, considers it a matter of debate and that it (SCH) is a cardiovascular risk factor. Primary prevention and intervention through risk factor modification can be effective in children and will reduce the morbidity and mortality from this disease in future.

CONCLUSION

Childhood obesity may coexist with sub clinical hypothyroidism and may develop in to hypothyroidism with irreversible organ damage. The present study revealed the prevalence of sub clinical hypothyroidism as 8.43% in the whole sample (n=83). It is suggested that obese children with minimum organ damage may be investigated to prevent the permanent organ damage in future.

Grant Support, Financial Disclosure and Conflict of Interest

The study was supported financially from the research fund of the Gomal University, Dera Ismail Khan.

REFERENCES

1. Reinehr T, de Sousa G, Andler W. Hyperthyrotropinemia in obese children is reversible after weight loss and is not related to lipids. J din Endocrinol Metab 2006;91 :3088-91.

2. lacobellis G, Ribaudo MC, Zappaterreno A, Jannucci CV, and Leonetti F. Relationship of thyroid function with body mass index, leptin, insulin sensitivity and adiponectin in euthyroid obese women. din Endocrinol (Oxf) 2005 ;62 :487-9 1.

3. Reinehr T, Andler W. Thyroid hormones before and after weight loss in obesity. Arch Dis Child 2002;87:320-3.

4. Radetti G, Kleon W, Buzi F, Crivellaro C, Pappalardo L, di lorgi N, et al. Thyroid function and structure are affected in childhood obesity. J Clin Endocrinol Metab 2008;93:4749-54.

5. Harris M, Aschkenasi C, Elias CF, Chandrankunnel A, Nillni BA, Bjorbek C, et a!. Transcriptional regulation of the thyrotropin-releasing hormone gene by leptin and melanocortin signaling. J Clin Invest 2001; 107: 111-20.

6. Burman KD, Latham KR, Djuh YY, Smallridge RC, Tseng YCL, Lukes YG, et al. Solubilized nuclear thyroid hormone receptors in circulating human mononuclear cells. J Clin Endocrinol Metab 1980;51:106-16.

7. Sturks MI, Ocampo E. Sub clinical thyroid disease. Am J Med 1996;100:217-23.

8. Hak AE, Pols HA, Visser TJ, Drexhage HA, Hofman A, Witteman JC. Sub clinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam study. Ann Intern Med 2000;132:270-8. 9. Chu JW, Crapo LM. Clinical perspective: the treatment of subclinical hypothyroidism is seldom necessary. J Clin Endocrinol Metab 2001;86:4591-9.

10. McDermott MT, Ridgway EC. Clinical perspective: subclinical hypothyroidism is mild thyroid failure and should be treated. J din Endocrinol Metab 2001;86:4585-90.

11. World Health Organization. Physical Status: the use and interpretation of anthropometry. Geneva: WHO; 1995.

12. Hay ID, Bayer MF, Kaplan MM, Klee GG, Larsen PR, Spencer CA. American thyroid association assessment of current free thyroid hormone and thyrotropin measurements and guidelines for future clinical assays. Clin Chem 1991;37:2002-8.

13. ott L. An introduction to statistical methods on data analysis. Duxbury Press, Boston 1984; p.775.

14. Bhatti AU. Statistical producers for analysis of Agriculture Research Experiment. Department of Soil and Environmental sciences, NWFP. Agriculture University, Peshawar, Pakistan 2006; p.293.

15. Cooper DS. Sub clinical hypothyroidism. N Engl J Med 200 l;345:260-5.

16. Hollowell JG, Staehling NW, Flanders WD, Gunter EW, Spencer CA, Braverman LE. Serum TSH, T (4) and thyroid antibodies in the United States population (1988-1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 2002;87:489-99.

17. Karmisholt J, Andersen S, Laurberg P. Variation in thyroid function tests in patients with stable untreated sub clinical hypothyroidism. Thyroid 2008; 18:303-8.

18. Herrick B. Subclinical hypothyroidism. Am Fam Physician 2008;77:953-5.

19. VilIar HC, Saconato H, Valente 0, Atallah AN. Thyroid hormone replacement for subclinical hypothyroidism. Cochrane Database Sys Rev 2007;(3):CD003419.

20. Han Kumar Ky, Verma A, Modi KD, Muthukrishnan J. Obesity and thyrotropinemia. Indian J Pediatr 2009;76:933-5.

21. Georges-Gobinet A, Pedeboscq S, Malanda H, Bordenave L. Assessment of thyrotropin, free thyroxine and free triiodothyronine concentrations in healthy children measured by radioisotopic assays. Immunoanalyse and Biologie Specialisee 2001; 16:119-21.

22. Vanderpump MP, Tunbridge WM, French JM, Appleton D, Bates D, Clark F, et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol (OxI) 1995;43:55-68.

23. Mansourian AR, Ghaemi E, Ahmadi AR, Marjani AJ, Saifi A, Bakhshandehnosrat S. Serum lipid level alterations in subclinical hypothyroid patients in Gorgan (South East of Caspian Sea). J Chin Clin Med 2008;3:206-10.

24. Razvi S. Shakoor A, Vanderpump M, Weaver JU, Pearce SH. The influence of age on the relationship between subclinical hypothy- roidism and ischemic heart disease: a metaanalysis. J Clin Endocrinol Metab 2008;93 :2998-3007.

25. Fatourechi V. Subclinical hypothyroidism: an update for primary care physicians. Mayo din Proc 2009;84:65-71.

CONTRIBUTORS

MR conceived the idea. IA supervised the study. FR helped in designing of tables and had done the statistical analysis. FR and MHR helped in typing the manuscript and collection of literature for the discussion of manuscript.

This article may be cited as: Ramzan M, Ali I, Ramzan F, Ramzan F, Ramzan MH. Prevalence of Sub Clinical Hypothyroidism in School Children (6-11 years) ofDera Ismail Khan. J Postgrad Med Inst 2012; 26(1): 22-8.

1, 2, Department of Chemistry, Gomal University,tm, Dera Ismail Khan - Pakistan

3Department of Animal Sciences, Faculty of, Biological Sciences, Quaid-i-Azam University, Islamabad - Pakistan.

4Department of Microbiology, Faculty of, Biological Sciences, Quaid-i-Azam University, Islamabad - Pakistan

5Khyber Teaching Hospital, Peshawar - Pakistan, Address for Correspondence: Dr. Muhammad Ramzan, Department of Biochemistry, Peshawar Medical College, Peshawar - Pakistan, E-mail: dr.ramzan49@gmail.com Date Received: January 31, 2011, Date Revised: December 7, 2011, Date Accepted: December 22, 2011,
COPYRIGHT 2012 Asianet-Pakistan
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2012 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Author:Ramzan, Muhammad; Ali, Irshad; Ramzan, Faiqah; Ramzan, Fain; Ramzan, Muhammad Hans
Publication:Journal of Postgraduate Medical Institute
Article Type:Report
Geographic Code:9PAKI
Date:Mar 31, 2012
Words:3457
Previous Article:ASSESSING THE EFFICACY OF DANSHENFORM COMPOUND IN PATIENTS WITH STABLE ANGINA PECTORIS.
Next Article:FREQUENCY OF DIABETIC RETINOPATHY IN A TERTIARY CARE HOSPITAL USING DIGITAL RETINAL IMAGING TECHNOLOGY.
Topics:

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters |